Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 12 Purpura 1 Paraproteinemias 1 Neoplasms 1 Nausea 1 Natural Killer/T-cell Lymphoma 1 Macroglossia 1 Lymphoproliferative Disorders 1 Lymphadenopathy 1 Immunoproliferative Disorders 1 Immunoglobulin Light-chain Amyloidosis 1 Hepatomegaly 1 Hematologic Neoplasms 1 Gastrointestinal Hemorrhage 1 Diarrhea 1 Constipation 1

Interventions

isatuximab 1 cemiplimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Natural Killer/T-cell Lymphoma × isatuximab × Clear all

NCT04763616 2026-04-27

ICING

Samsung Medical Center

Phase 2 Completed

Natural Killer/T-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡